10/31/2007

Polytec PT GmbH, Polymere Technologien

RTV Gel Expands NuSil Technology’s Line of Healthcare Silicone Materials

NuSil Technology, a cutting-edge manufacturer of silicone-based materials for healthcare, aerospace, electronics and photonics, has launched an extension to its line of healthcare gels. MED- 6380 is ideal for use in healthcare applications that require an unfilled, room-temperature vulcanizing (RTV) material.

The low cure temperature of this material makes it ideal for incorporating heat-sensitive additives such as pharmaceutical compounds, biocides, excipients and other functional fillers. The MED-6380 firm RTV gel cures without heat and is filler-free. In addition, this pourable, three-component gel can be molded or used as a soft, conformal coating.

“This addition to NuSil’s product line offer customers even more options for healthcare and drug delivery applications,” said Brian Nash, vice president of Marketing and Sales. “We believe the low temperature cure creates more device possibilities incorporating temperature sensitive active pharmaceuticals and excipients.”

10/31/2007

Polytec PT GmbH, Polymere Technologien

RTV Gel Expands NuSil Technology’s Line of Healthcare Silicone Materials

NuSil Technology, a cutting-edge manufacturer of silicone-based materials for healthcare, aerospace, electronics and photonics, has launched an extension to its line of healthcare gels. MED- 6380 is ideal for use in healthcare applications that require an unfilled, room-temperature vulcanizing (RTV) material.

The low cure temperature of this material makes it ideal for incorporating heat-sensitive additives such as pharmaceutical compounds, biocides, excipients and other functional fillers. The MED-6380 firm RTV gel cures without heat and is filler-free. In addition, this pourable, three-component gel can be molded or used as a soft, conformal coating.

“This addition to NuSil’s product line offer customers even more options for healthcare and drug delivery applications,” said Brian Nash, vice president of Marketing and Sales. “We believe the low temperature cure creates more device possibilities incorporating temperature sensitive active pharmaceuticals and excipients.”